This article outlines a systematic approach for clinicians to identify the underlying causes of small fiber neuropathy (SFN), a condition where standard tests often fail to provide an etiology. The authors categorize diagnostic investigations into first-line blood tests, which screen for common metabolic, endocrine, and inflammatory triggers like diabetes, vitamin deficiencies, and autoimmune disorders. For complex cases, they propose second-line investigations involving specialized genetic testing and advanced biomarkers tailored to specific clinical warning signs. By providing a structured diagnostic algorithm, the text helps medical professionals move beyond a symptom-only diagnosis to find treatable origins. The research emphasizes that while many cases remain idiopathic, exhaustive screening for immunological and hereditary factors is essential for effective patient management. Ultimately, the source serves as a practical guide to rationalizing laboratory tests to improve the diagnostic yield in clinical practice.